ipamorelin peptide rockwall Ipamorelin | Synthesis Peptides
Description
Phase (approx.) Cagrilintide dose Frequency Weeks 14 0.25 mg Once weekly Weeks 58 0.5 mg Once weekly Weeks 912 1.0 mg Once weekly Weeks 1316 1.7 mg Once weekly Week 17 onward 2.4 mg (max studied) Once weekly This step-wise schedule mirrors the titration used in cagrilintide and CagriSema studies ( Lau et al., Lancet 2021
Catur, L., & Torun, C
Fialova D
doi: 10.1007/s13402-015-0254-4 68 KhemissaFMineurLAmsellemCAssenatERamdaniMBachmannPet al
1999;274(1):516-521.[DOI] 17
This page does not recommend BPC-157 and does not provide dosing or administration guidance
